XL Axiata Tbk. vs Champion Pacific Indonesia Tbk. — how do they compare? XL Axiata Tbk. trades at Rp2,600 (market cap 46.41T, 6.88M 24h volume), while Champion Pacific Indonesia Tbk. trades at Rp416 (market cap 384.1B, 8.4K 24h volume). The key difference: XL Axiata Tbk. is far larger — about 120.8× Champion Pacific Indonesia Tbk.'s market cap, and XL Axiata Tbk. is more actively traded (6.88M versus 8.4K). Which is the better fit depends on your goals.
| EXCL | IGAR | |
|---|---|---|
Market Cap | 46.41T | 384.1B |
Volume | 6.88M | 8.4K |
Lot | 68.84K | 84 |
Turnover | 17.79B | 3.49M |
Average Price | 2,584.75 | 415.95 |
Value | 17.79B | 3.49M |
Indicative Equilibrium Price | 2,600 | 414 |
Indicative Equilibrium Volume | 1.53K | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT XL Axiata Tbk (the Company) which was previously known as PT Excelcomindo Pratama Tbk, was initially established under the name PT Grahametropolitan Lestari. The Company was established on Oct 6th, 1989.The articles of association have been amended several times, most recently on Aug 2, 2005, concerning among other the change of par value, equity and public offering. The company started its operation since October 1996 and was the 3rd biggest company in Indonesia for the number of customer and income.
Read more on EXCL →PT Champion Pacific Indonesia Tbk (The Company) formerly PT Kageo Igar Jaya was established under the name of PT Igar Jaya based on Notarial deed No. 195 dated October 30, 1975, of Mohamad Said Tadjoedin, SH, Notary in Jakarta. Igar Jaya was founded in October 1975 in the Republic of Indonesia as a joint venture with Owens-Illinois, a leading glass container manufacturer in the United States, initially in the production of glass vial and ampoules to support Indonesia’s pharmaceutical industry. However since 1987, due to customer demand, the Company has expanded to the business of plastic, aluminum foil (flexible packaging) and paper folding carton packaging products as well as disposable syringe not only to meet the needs of Indonesia’s pharmaceutical industry but also its cosmetic and food industries. In 1988, the Company relinquished its joint venture status with a view to entering the global market and today has customers in 14 countries outside Indonesia. These include: Britain, Bangladesh, Canada, Guinea, Malaysia, Mauritius, Pakistan, the Philippines, Saudi Arabia, Singapore, Thailand, Trinidad & Tobago, the United States and Zaire.
Read more on IGAR →